This idea is supported by a previous study that combined a treatment of IL-6 and IL-21 blockade in the collagen-induced RA model triggering a synergistic effect and significantly decreasing the number of Th17 cells [54]. This evidence concerns the gene IL21 and rheumatoid arthritis.